BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7911574)

  • 1. An animal model for measuring behavioral responses to anxiogenic and anxiolytic manipulations.
    Stout JC; Weiss JM
    Pharmacol Biochem Behav; 1994 Mar; 47(3):459-65. PubMed ID: 7911574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs.
    Thompson BL; Rosen JB
    Neuropharmacology; 2006 Jan; 50(1):57-68. PubMed ID: 16185722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Anxiolytic" action of diazepam and abecarnil in a modified open field test.
    Rex A; Stephens DN; Fink H
    Pharmacol Biochem Behav; 1996 Apr; 53(4):1005-11. PubMed ID: 8801571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of diazepam and A beta-carboline on open-field and T-maze behaviors in 2-day-old chicks.
    Marín RH; Martijena ID; Arce A
    Pharmacol Biochem Behav; 1997 Dec; 58(4):915-21. PubMed ID: 9408196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?
    File SE; Zangrossi H
    Psychopharmacology (Berl); 1993; 110(1-2):240-4. PubMed ID: 7870892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat.
    Merlo Pich E; Samanin R
    Pharmacol Res; 1989; 21(5):595-602. PubMed ID: 2574443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of anxiolytics and beta-receptor blocking drugs on novelty-oriented ("neophobic") behavior in the rat.
    Delini-Stula A; Hunn C
    Pharmacopsychiatry; 1988 Jul; 21(4):186-91. PubMed ID: 2905063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic and anxiogenic drug effects on male and female gerbils in the black-white box.
    Bradley BF; Bridges NJ; Starkey NJ; Brown SL; Lea RW
    Behav Brain Res; 2011 Jan; 216(1):285-92. PubMed ID: 20723567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions.
    Micale V; Tamburella A; Leggio GM; Mazzola C; Li Volsi V; Drago F
    Pharmacol Biochem Behav; 2008 Sep; 90(3):463-9. PubMed ID: 18495229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety.
    Fernandez F; Misilmeri MA; Felger JC; Devine DP
    Neuropsychopharmacology; 2004 Jan; 29(1):59-71. PubMed ID: 14532912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nitric oxide donor molsidomine induces anxiolytic-like behaviour in two different rat models of anxiety.
    Kalouda T; Pitsikas N
    Pharmacol Biochem Behav; 2015 Nov; 138():111-6. PubMed ID: 26363313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural effects of anxiogenic agents in the common marmoset.
    Carey GJ; Costall B; Domeney AM; Jones DN; Naylor RJ
    Pharmacol Biochem Behav; 1992 May; 42(1):143-53. PubMed ID: 1528937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fear-potentiation in the elevated plus-maze test depends on stressor controllability and fear conditioning.
    Korte SM; De Boer SF; Bohus B
    Stress; 1999 Aug; 3(1):27-40. PubMed ID: 19016191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of rat exploratory behavior using the exploration box test.
    Otter MH; Matto V; Sõukand R; Skrebuhhova T; Allikmets L; Harro J
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):683-91. PubMed ID: 9580470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primate displacement activities as an ethopharmacological model of anxiety.
    Schino G; Perretta G; Taglioni AM; Monaco V; Troisi A
    Anxiety; 1996; 2(4):186-91. PubMed ID: 9160621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine.
    Lin HQ; Burden PM; Christie MJ; Johnston GA
    Pharmacol Biochem Behav; 1999 Mar; 62(3):403-8. PubMed ID: 10080230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic and anxiogenic effects of diazepam in male mice with different experience of aggression.
    Kudryavtseva NN; Bondar' NP
    Bull Exp Biol Med; 2002 Apr; 133(4):372-6. PubMed ID: 12124649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic-like effect of group housing on stress-induced behavior in rats.
    Andrade CS; Guimarães FS
    Depress Anxiety; 2003; 18(3):149-52. PubMed ID: 14625880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release.
    Merali Z; Khan S; Michaud DS; Shippy SA; Anisman H
    Eur J Neurosci; 2004 Jul; 20(1):229-39. PubMed ID: 15245495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.
    Dalvi A; Rodgers RJ
    Pharmacol Biochem Behav; 1999 Apr; 62(4):727-34. PubMed ID: 10208379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.